These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 18928510)

  • 1. Is a computer crossmatch in the absence of an immediate-spin antibody screen adequate for persons identified to be at increased risk of forming new blood group antibodies?
    Sandler SG; Abedalthagafi M; Langeberg A
    Transfusion; 2008 Oct; 48(10):2265-6. PubMed ID: 18928510
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transfusion for patients with immunohematological problems].
    Tohyama H; Uchikawa M
    Rinsho Byori; 1982 Oct; 30(10):1089-95. PubMed ID: 6763640
    [No Abstract]   [Full Text] [Related]  

  • 3. Early onset multiple alloimmunization (anti-E and anti-Jkb) in a thalassaemic.
    Thakral B; Saluja K; Sharma RR; Marwaha N; Marwaha RK
    Clin Lab Haematol; 2006 Aug; 28(4):286-7. PubMed ID: 16898974
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of anti-Coa antibodies of the Colton blood group system and their significance in hemotherapy].
    Kuśnierz G; Bragiel I; Nowakowska E; Cwirko Z
    Acta Haematol Pol; 1983; 14(2):117-24. PubMed ID: 6673468
    [No Abstract]   [Full Text] [Related]  

  • 5. Red blood cell alloimmunization in sickle cell disease-prevalence and trends: a single-center cross-sectional study from United Kingdom.
    Mijovic A; Perera IG; Thein SL
    Transfusion; 2013 Dec; 53(12):3279-80. PubMed ID: 24320815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Irregular erythrocytic antibodies as an obstacle to transfusion].
    Uhlig R; Endert G; Lammel G
    Z Arztl Fortbild (Jena); 1984; 78(20):849-52. PubMed ID: 6523909
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating the clinical significance of blood group alloantibodies that are causing problems in pretransfusion testing.
    Garratty G
    Vox Sang; 1998; 74 Suppl 2():285-90. PubMed ID: 9704458
    [No Abstract]   [Full Text] [Related]  

  • 8. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch.
    Shulman IA
    Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosensitization in patients receiving multiple blood transfusions.
    Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD
    Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Titres of alloantibodies against A and B blood types in non-pedigree domestic cats in Turkey: assessing the transfusion reaction risk.
    Gurkan M; Arikan S; Ozaytekin E; Dodurka T
    J Feline Med Surg; 2005 Oct; 7(5):301-5. PubMed ID: 15914059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood transfusion and monitoring. Immediate transfusion reactions. Erythrocyte transfusion].
    Riche H
    Soins; 1996 Apr; (605):23-6. PubMed ID: 8716245
    [No Abstract]   [Full Text] [Related]  

  • 13. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ok(a) antigen and anti-Ok(a) antibody].
    Okubo M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():780-1. PubMed ID: 20942188
    [No Abstract]   [Full Text] [Related]  

  • 15. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
    Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
    Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible insensitivity of the polybrene antibody screen to detect anti-Jka.
    Liu F; Liu J
    Ann Clin Lab Sci; 2006; 36(1):101-2. PubMed ID: 16501244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood and blood product transfusions. Immunological basis and indications].
    Andreu G
    Rev Prat; 2001 Feb; 51(3):299-305. PubMed ID: 11265428
    [No Abstract]   [Full Text] [Related]  

  • 18. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
    Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU
    Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current problems of blood transfusion. Responsibility of the physician in transfusion].
    Schönitzer D; Rosmanith P; Kilga-Nogler S
    Infusionsther Klin Ernahr; 1985 Aug; 12(4):170-4. PubMed ID: 4066002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.